While past efforts on the part of researchers and professionals have led to more effective treatments of the complications associated with SCD and little is known about the social epidemiology of SCD (that is, critical and accessible data on the physical, psychological and social aspects of SCD). Questions about the access, differential outcomes, and use of health and social services of persons with SCD, remain largely unanswered. To begin to add new knowledge to the understanding of the lives of persons with SCD, and to provide a state-level sociological counterpart to the CSSCD, the UAB Comprehensive SCD Center proposes to establish, maintain and use, a registry for persons with SCD in Alabama.
Specific Aim 1 : To develop and implement a SCD client registry for the purpose of maintaining key epidemiologic, socio-demographic, health care and social data on persons with SCD that will be used for planning clinical care, case management, advocacy, and research.
Specific Aim 2 : To use the first wave core and supplemental data from the registry to: (a) describe the frequency and demographics of SCD in Alabama; (b) document the prevalence of (i) self-reported illness experiences, and (ii) health and human services access and use, of persons with SCD in Alabama; and (c) to test research hypotheses identifying factors associated with the differential service experiences, gaps and barriers in the access to, and use of, the existing human and health care service systems for persons with SCD in Alabama. These hypotheses are: 2.1 Persons with SCD (or their parental caretakers) living in urban counties of Alabama will be more likely to report greater knowledge of available services (perceived availability), greater access to (perceived access), use of, and satisfaction with these services, than rural persons with SCD. 2.2. Children and adolescents with SCD (or their primary caretakers) living in Alabama will be more likely to have reports of greater knowledge of available services (perceived availability), greater access to (perceived access), use of, and satisfaction with these services, than adults with SCD living in Alabama. Methodology; Based on Specific Aim 1: The development of a SCD Registry will involve two phases: planning and development (months 1 to 11 of year 01) and implementation (Years 02 through 03 and every two years thereafter). Based on Specific Aim 2: Beginning in year 04, wave one data from the registry will be organized and linked with state-level data. Using epidemiologic methods client characteristics, service use, access and satisfaction patterns will be documented; using bivariate and multi-variable statistics and the framework of the Anderson and Aday Access model as a guide, hypothesized relationships will be tested and conclusions will be drawn.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Comprehensive Center (P60)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Alabama Birmingham
United States
Zip Code
Coats, Mamie T; Benjamin, W H; Hollingshead, S K et al. (2005) Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae. Vaccine 23:4257-62
Telfair, Joseph; Alexander, Leah R; Loosier, Penny S et al. (2004) Providers' perspectives and beliefs regarding transition to adult care for adolescents with sickle cell disease. J Health Care Poor Underserved 15:443-61
Briles, David E; Hollingshead, Susan K; Paton, James C et al. (2003) Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 188:339-48
Liu, Enli; Jelinek, Jaroslav; Pastore, Yves D et al. (2003) Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood 101:3294-301
Aslan, Mutay; Ryan, Thomas M; Townes, Tim M et al. (2003) Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 278:4194-204
Lim, Dong Gun; Sweeney, Scott; Bloodsworth, Allison et al. (2002) Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc Natl Acad Sci U S A 99:15941-6
Coles, Barbara; Bloodsworth, Allison; Eiserich, Jason P et al. (2002) Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J Biol Chem 277:5832-40
Coles, Barbara; Bloodsworth, Allison; Clark, Stephen R et al. (2002) Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res 91:375-81
Robinson, D Ashley; Briles, David E; Crain, Marilyn J et al. (2002) Evolution and virulence of serogroup 6 pneumococci on a global scale. J Bacteriol 184:6367-75
O'Donnell, V B; Freeman, B A (2001) Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 88:12-21

Showing the most recent 10 out of 22 publications